NUTX

+ Watchlist + Portfolio

Nutex Health Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $190.62
52-Week Range: $77.21 – $204.00
Market Cap: $1.29B
P/E (TTM): 7.31
EPS (TTM): 25.79
Dividend Yield: —

Advanced Metrics

Price/Book: 3.27
PEG Ratio: —
Return on Equity: 64.56%
Return on Assets: 33.32%
Gross Margin: 54.51%
Operating Margin: 57.75%
Profit Margin: 21.25%
Current Ratio: 5.00
Debt/Equity: 0.68
Total Debt: $347.34M
Free Cash Flow: $130.75M
Revenue Growth: -13.60%
Earnings Growth: —
Enterprise Value: $1.56B

NUTX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$219.29M	$247.65M	$479.95M	$875.26M
Cost of Revenue	$203.87M	$212.87M	$283.69M	$430.98M
Gross Profit	$15.42M	$34.77M	$196.26M	$444.28M
Selling, General & Admin	$20.00M	$36.07M	$58.48M	$168.66M
Operating Expenses	$20.00M	$36.28M	$58.48M	$168.66M
Operating Income	-$4.58M	-$1.51M	$137.78M	$275.63M
EBITDA	-$394.03M	-$14.58M	$148.73M	$287.54M
Pretax Income	-$419.65M	-$48.49M	$109.83M	$244.78M
Income Tax	$13.09M	-$5.07M	$15.02M	$64.42M
Net Income	-$424.78M	-$45.79M	$52.10M	$70.79M
Diluted EPS	-100.50	-10.50	9.71	10.48
Diluted Shares	4.23M	4.36M	5.37M	6.76M

NUTX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$34.26M	$22.00M	$40.64M	$185.57M
Receivables	$58.32M	$62.78M	$236.05M	$325.42M
Inventory	$3.53M	$3.39M	$2.85M	$2.87M
Current Assets	$97.97M	$90.85M	$292.48M	$538.81M
Total Assets	$431.75M	$398.25M	$655.32M	$918.52M
Current Liabilities	$54.86M	$58.31M	$154.22M	$157.91M
Long-Term Debt	$23.05M	$26.31M	$22.47M	$29.17M
Total Debt	$267.20M	$275.76M	$340.30M	$351.39M
Total Liabilities	$311.42M	$319.14M	$466.79M	$495.09M
Retained Earnings	-$363.29M	-$409.07M	-$356.98M	-$286.19M
Shareholders' Equity	$95.86M	$61.45M	$132.44M	$329.45M
Working Capital	$43.11M	$32.54M	$138.25M	$380.90M
Net Debt	$3.97M	$18.49M	—	—

NUTX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$50.61M	$1.26M	$23.15M	$248.13M
Capital Expenditure	-$14.63M	-$9.50M	-$2.30M	-$2.53M
Free Cash Flow	$35.97M	-$8.24M	$20.85M	$245.60M
Depreciation & Amortisation	$13.13M	$17.59M	$18.97M	$20.53M
Stock-Based Compensation	$189.58K	$2.84M	$16.55M	$117.00M
Investing Cash Flow	-$4.34M	-$11.24M	-$5.61M	-$5.24M
Financing Cash Flow	-$48.13M	-$2.27M	$1.09M	-$97.95M
Dividends Paid	-$51.23M	-$5.21M	-$6.44M	-$74.28M
Share Repurchases	—	$0.00	$0.00	-$5.00M
Net Change in Cash	-$1.86M	-$12.25M	$18.64M	$144.93M

NUTX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$211.79M	$243.99M	$267.80M	$151.68M	$216.49M
Cost of Revenue	$93.45M	$119.06M	$112.92M	$105.54M	$124.75M
Gross Profit	$118.34M	$124.92M	$154.88M	$46.14M	$91.73M
Selling, General & Admin	$37.68M	$91.25M	$24.51M	$15.22M	$10.46M
Operating Expenses	$37.68M	$91.25M	$24.51M	$15.22M	$10.46M
Operating Income	$80.66M	$33.68M	$130.37M	$30.92M	$81.27M
EBITDA	$82.43M	$34.66M	$134.39M	$36.06M	$86.73M
Pretax Income	$71.22M	$23.73M	$123.94M	$25.89M	$76.56M
Income Tax	$20.41M	$7.59M	$27.14M	$9.29M	$13.80M
Net Income	$21.22M	-$17.70M	$55.44M	$11.83M	$46.81M
Diluted EPS	3.33	-2.95	7.76	—	6.52
Diluted Shares	6.37M	6.00M	7.14M	—	7.18M

NUTX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$84.73M	$96.73M	$166.05M	$185.57M	$207.35M
Receivables	$299.34M	$354.96M	$406.86M	$325.42M	$345.90M
Inventory	$3.12M	$2.27M	$3.16M	$2.87M	$4.68M
Current Assets	$401.52M	$473.02M	$592.65M	$538.81M	$579.65M
Total Assets	$761.92M	$841.03M	$964.52M	$918.52M	$957.32M
Current Liabilities	$176.57M	$194.87M	$185.46M	$157.91M	$184.44M
Long-Term Debt	$21.73M	$20.46M	$25.57M	$29.17M	$24.26M
Total Debt	$341.36M	$345.25M	$358.60M	$351.39M	$349.09M
Total Liabilities	$487.04M	$504.15M	$526.49M	$495.09M	$515.26M
Retained Earnings	-$342.26M	-$353.46M	-$298.02M	-$286.19M	-$239.38M
Shareholders' Equity	$197.11M	$235.25M	$317.17M	$329.45M	$346.29M
Working Capital	$224.95M	$278.15M	$407.19M	$380.90M	$395.21M

NUTX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$50.97M	$27.26M	$99.51M	$70.39M	$75.52M
Capital Expenditure	-$64.00K	-$751.00K	-$302.00K	-$1.41M	-$1.20M
Free Cash Flow	$50.90M	$26.51M	$99.21M	$68.98M	$74.32M
Depreciation & Amortisation	$5.09M	$5.25M	$5.00M	$5.19M	$5.49M
Stock-Based Compensation	$27.64M	$78.75M	$13.22M	-$2.60M	-$3.92M
Investing Cash Flow	-$64.00K	$196.00K	-$302.00K	-$5.07M	-$1.20M
Financing Cash Flow	-$6.81M	-$15.45M	-$29.90M	-$45.79M	-$49.55M
Dividends Paid	-$7.36M	-$11.41M	-$23.40M	-$32.10M	-$15.36M
Share Repurchases	$0.00	—	—	—	-$31.73M
Net Change in Cash	$44.09M	$12.00M	$69.31M	$19.53M	$24.77M

Market Snapshot

About

Nutex Health Inc. owns and operates hospital facilities and healthcare operations in Texas. The company provides emergency medical services, hospital care, and other healthcare-related services.